SERUM ALPHA-FETO-PROTEIN AND PRIMARY CANCER OF LIVER IN MAN
SERUM ALPHA-FETO-PROTEIN AND PRIMARY CANCER OF LIVER IN MAN
复制标题
DOI：
10.1002/1097-0142(197006)25:6
复制
发表时间：
1970-01-01
期刊：
影响因子：
6.2
通讯作者：
GEDDES, EW
中科院分区：
文献类型：
--
作者：
PURVES, LR;BERSOHN, I;GEDDES, EW
通过定量甲胎蛋白（AFP）免疫扩散法对肝功能检查异常的病例、班图献血者、新生儿、患有原发性肝癌的白人患者和患有原发性肝癌的班图男性矿工进行了研究。没有发生假阳性AFP检测，78%的原发性肝癌患者呈阳性。更敏感的测试能够进一步提高阳性率。
Cases with abnormal liver function tests, Bantu blood donors, neonates, Caucasian patients with primary cancer of the liver, and male Bantu mine workers with primary cancer of the liver have been investigated by means of a quantitative alpha‐feto‐protein (AFP) immunodiffusion assay. No false‐positive AFP tests have occurred, and 78% of primary liver cancer patients are positive. More sensitive tests are capable of increasing the positivity rate still further.